Athira pharma aktie
Athira Pharma is a late clinical stage American biopharmaceutical company developing small molecules to restore neuronal health and stop the neurodegeneration brought on by diseases such as Alzheimer's disease and Parkinson's disease. The company's lead candidate, ATH-1017, is in human studies for Alzheimer's disease as of 2024. The company was founded in 2011 and is headquartered in Seattle. Funding that supports the c… WebAt Athira, we are committed to restoring, rebuilding and retaining connections. Our scientific philosophy is rooted in supporting a healthy neuronal network, improving the lives of …
Athira pharma aktie
Did you know?
WebApr 10, 2024 · Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its lead product candidate is ATH-1017 Fosgonimeton, a small molecule designed to enhance the activity of hepatocyte growth factor (HGF) and its receptor, … WebApr 10, 2024 · A high-level overview of Athira Pharma, Inc. (ATHA) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
WebAug 26, 2024 · Seattle’s Athira Pharma files for IPO to fund quest for Alzheimer’s and Parkinson’s breakthroughs. by Taylor Soper on August 26, 2024 at 4:01 pm August 26, 2024 at 4:01 pm. WebTo Restore Lives by Advancing Bold Therapies for Neuronal Health, Thoughtfully and Urgently. We are a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration. At Athira, we are committed to restoring, rebuilding and retaining connections.
WebAccording to the current price, Athira Pharma is 108.97% away from the 52-week low. What was the 52-week high for Athira Pharma stock? The high in the last 52 weeks of Athira … WebAug 16, 2024 · Athira Pharma extends Alzheimer’s clinical trial, adds new execs after CEO placed on leave. by Charlotte Schubert on August 16, 2024 at 4:37 pm August 18, 2024 at 12:44 pm.
WebMar 28, 2024 · Athira Pharma, Inc., headquartered in the Seattle, Washington area, is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration. Athira aims to provide rapid cognitive improvement and alter the course of neurological diseases with its novel mechanism of …
WebMar 15, 2024 · Athira Pharma Presents Preclinical Data Supporting Therapeutic Potential of Fosgonimeton for Alzheimer’s and Parkinson’s Diseases at AD/PD™ 2024 International … eysenck psychoticismWebAthira Pharma Inc Registered Shs Aktie Profil. Die Athira Pharma Inc Registered Shs Aktie wird unter der ISIN US04746L1044 an den Börsen NASDAQ, Bats und NASDAQ … eysenck personality typesWebMar 31, 2024 · Der aktuelle Athira Pharma Realtimekurs (31.03.23) liegt bei 2,500 $. Damit ist die Athira Pharma Aktie (A2QCFW) in 24 Stunden um +1,63 % gestiegen. does charge card build creditWebJun 18, 2024 · What happened. On a generally lousy day for stocks, Athira Pharma ( ATHA 3.80%) did even worse than many decliners on Friday. The shares fell by almost 39% on the day, on disquieting news about ... does charge off mean closedWebJan 28, 2024 · Leen Kawas led Athira Pharma as CEO for seven years before she was forced to resign in 2024. Leen Kawas received a call from billionaire investor Richard Kayne within 30 minutes of losing her job ... does charge of the light brigade glorify warWebOct 11, 2024 · Athira Pharma GAAP EPS of -$2.53 misses by $0.13: 23.03. Athira Pharma, Inc. - S-8, Securities to be offered to employees in employee benefit plans: 23.03. Athira Pharma, Inc. - 8-K, Current ... eysenck psychology theoryWebMar 23, 2024 · Athira Pharma, Inc., headquartered in the Seattle, Washington area, is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration. Athira aims to provide rapid cognitive improvement and alter the course of neurological diseases with its novel mechanism of … eysenck psychology personality